...
glto-img

Galecto Inc, Common Stock

GLTO

NAQ

$5.62

-$0.04

(-0.71%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$7.45M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
10.50K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.25
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$5.3 L
$23.5 H
$5.62

About Galecto Inc, Common Stock

Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB2064, which is in Phase IIa for the treatment of myelofibrosis. It also develops GB2064, a selective oral small molecule inhibitor of LOXL2 that is in Phase 2a clinical trial for the treatment of fibrotic diseases, including cancer and myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase IIa for the treatment of cancer, as well as in Phase Ib/IIa for fibrosis. Galecto, Inc. was founded in 2011 and is headquartered in Copenhagen, Denmark. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameGLTOSectorS&P500
1-Week Return6.04%-2.12%0.77%
1-Month Return-19.6%-2.54%2.65%
3-Month Return-49.64%-6.28%12.3%
6-Month Return-58.14%-1.36%13.48%
1-Year Return-65.94%9.29%33.47%
3-Year Return-91.04%10.05%32.22%
5-Year Return-98.5%43.69%92.85%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue111.00K188.00K441.00K490.00K830.00K[{"date":"2019-12-31","value":13.37,"profit":true},{"date":"2020-12-31","value":22.65,"profit":true},{"date":"2021-12-31","value":53.13,"profit":true},{"date":"2022-12-31","value":59.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(111.00K)(188.00K)(441.00K)(490.00K)(830.00K)[{"date":"2019-12-31","value":-11100000,"profit":false},{"date":"2020-12-31","value":-18800000,"profit":false},{"date":"2021-12-31","value":-44100000,"profit":false},{"date":"2022-12-31","value":-49000000,"profit":false},{"date":"2023-12-31","value":-83000000,"profit":false}]
Gross Margin(Infinity%)(Infinity%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses38.97M33.64M52.23M61.21M35.63M[{"date":"2019-12-31","value":63.67,"profit":true},{"date":"2020-12-31","value":54.96,"profit":true},{"date":"2021-12-31","value":85.33,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.21,"profit":true}]
Operating Income(38.97M)(33.64M)(52.23M)(61.21M)(39.91M)[{"date":"2019-12-31","value":-3897100000,"profit":false},{"date":"2020-12-31","value":-3363700000,"profit":false},{"date":"2021-12-31","value":-5222700000,"profit":false},{"date":"2022-12-31","value":-6120700000,"profit":false},{"date":"2023-12-31","value":-3990500000,"profit":false}]
Total Non-Operating Income/Expense2.46M(1.20M)631.00K305.00K3.19M[{"date":"2019-12-31","value":77.27,"profit":true},{"date":"2020-12-31","value":-37.63,"profit":false},{"date":"2021-12-31","value":19.79,"profit":true},{"date":"2022-12-31","value":9.56,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(36.51M)(34.84M)(51.75M)(61.62M)(38.35M)[{"date":"2019-12-31","value":-3650700000,"profit":false},{"date":"2020-12-31","value":-3483700000,"profit":false},{"date":"2021-12-31","value":-5175200000,"profit":false},{"date":"2022-12-31","value":-6162400000,"profit":false},{"date":"2023-12-31","value":-3834900000,"profit":false}]
Income Taxes1.91M1.20M(475.00K)417.00K-[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":62.73,"profit":true},{"date":"2021-12-31","value":-24.83,"profit":false},{"date":"2022-12-31","value":21.8,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(38.42M)(36.04M)(51.28M)(62.04M)-[{"date":"2019-12-31","value":-3842000000,"profit":false},{"date":"2020-12-31","value":-3603700000,"profit":false},{"date":"2021-12-31","value":-5127700000,"profit":false},{"date":"2022-12-31","value":-6204100000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(36.51M)(34.84M)(51.75M)(61.88M)(45.94M)[{"date":"2019-12-31","value":-3650700000,"profit":false},{"date":"2020-12-31","value":-3483700000,"profit":false},{"date":"2021-12-31","value":-5175200000,"profit":false},{"date":"2022-12-31","value":-6188300000,"profit":false},{"date":"2023-12-31","value":-4594300000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(38.42M)(36.04M)(51.28M)(62.04M)(38.35M)[{"date":"2019-12-31","value":-3842000000,"profit":false},{"date":"2020-12-31","value":-3603700000,"profit":false},{"date":"2021-12-31","value":-5127700000,"profit":false},{"date":"2022-12-31","value":-6204100000,"profit":false},{"date":"2023-12-31","value":-3834900000,"profit":false}]
EPS (Diluted)-(100.38)(2.05)(2.43)(1.46)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-10038,"profit":false},{"date":"2021-12-31","value":-205,"profit":false},{"date":"2022-12-31","value":-243,"profit":false},{"date":"2023-12-31","value":-146,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

GLTO
Cash Ratio 8.06
Current Ratio 8.68
Quick Ratio 9.17

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

GLTO
ROA (LTM) -34.29%
ROE (LTM) -72.61%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

GLTO
Debt Ratio Lower is generally better. Negative is bad. 0.10
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.90

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

GLTO
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.35
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.46

FAQs

What is Galecto Inc share price today?

Galecto Inc (GLTO) share price today is $5.62

Can Indians buy Galecto Inc shares?

Yes, Indians can buy shares of Galecto Inc (GLTO) on Vested. To buy Galecto Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in GLTO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Galecto Inc be purchased?

Yes, you can purchase fractional shares of Galecto Inc (GLTO) via the Vested app. You can start investing in Galecto Inc (GLTO) with a minimum investment of $1.

How to invest in Galecto Inc shares from India?

You can invest in shares of Galecto Inc (GLTO) via Vested in three simple steps:

  • Click on Sign Up or Invest in GLTO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Galecto Inc shares
What is Galecto Inc 52-week high and low stock price?

The 52-week high price of Galecto Inc (GLTO) is $23.5. The 52-week low price of Galecto Inc (GLTO) is $5.3.

What is Galecto Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Galecto Inc (GLTO) is

What is Galecto Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Galecto Inc (GLTO) is 0.35

What is Galecto Inc dividend yield?

The dividend yield of Galecto Inc (GLTO) is 0.00%

What is the Market Cap of Galecto Inc?

The market capitalization of Galecto Inc (GLTO) is $7.45M

What is Galecto Inc’s stock symbol?

The stock symbol (or ticker) of Galecto Inc is GLTO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top